(Q53086376)

English

Antepartum dalteparin versus no antepartum dalteparin for the prevention of pregnancy complications in pregnant women with thrombophilia (TIPPS): a multinational open-label randomised trial.

scientific article published on 24 July 2014

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/25066248

Antepartum dalteparin versus no antepartum dalteparin for the prevention of pregnancy complications in pregnant women with thrombophilia (TIPPS): a multinational open-label randomised trial. (English)

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/25066248

human pregnancy

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

pregnant person

1 reference

based on heuristic

inferred from title

object named as

Joanne Said

10

0 references

Robert M Silver

24

object named as

Robert M Silver

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

object named as

Graeme Smith

19

0 references

author name string

Marc A Rodger

1

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/25066248

William M Hague

2

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/25066248

John Kingdom

3

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/25066248

Susan R Kahn

4

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/25066248

Alan Karovitch

5

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/25066248

Mathew Sermer

6

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/25066248

Anne Marie Clement

7

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/25066248

Suzette Coat

8

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/25066248

Wee Shian Chan

9

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/25066248

Evelyne Rey

11

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/25066248

Sue Robinson

12

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/25066248

Rshmi Khurana

13

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/25066248

Christine Demers

14

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/25066248

Michael J Kovacs

15

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/25066248

Susan Solymoss

16

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/25066248

Kim Hinshaw

17

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/25066248

James Dwyer

18

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/25066248

Sarah McDonald

20

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/25066248

Jill Newstead-Angel

21

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/25066248

Anne McLeod

22

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/25066248

Meena Khandelwal

23

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/25066248

Gregoire Le Gal

25

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/25066248

Ian A Greer

26

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/25066248

Erin Keely

27

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/25066248

Karen Rosene-Montella

28

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/25066248

Mark Walker

29

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/25066248

Philip S Wells

30

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/25066248

TIPPS Investigators

31

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/25066248

language of work or name

0 references

publication date

24 July 2014

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/25066248

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/25066248

384

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/25066248

9955

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/25066248

1673-1683

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/25066248

Trends in the incidence of venous thromboembolism during pregnancy or postpartum: a 30-year population-based study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960793-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Prothrombin and factor V mutations in women with a history of thrombosis during pregnancy and the puerperium

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960793-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Pregnancy-related mortality in the United States, 1987-1990.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960793-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Causes of death among stillbirths

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960793-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Outcomes of subsequent pregnancy after first pregnancy with early-onset preeclampsia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960793-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Risk of subsequent thromboembolism for patients with pre-eclampsia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960793-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Ante- and postnatal risk factors of venous thrombosis: a hospital-based case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960793-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Preeclampsia and fetal loss in women with a history of venous thromboembolism

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960793-5

7 January 2021

based on heuristic

inferred from DOI database lookup

The association of factor V leiden and prothrombin gene mutation and placenta-mediated pregnancy complications: a systematic review and meta-analysis of prospective cohort studies

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960793-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Thrombophilic disorders and fetal loss: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960793-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Increased frequency of genetic thrombophilia in women with complications of pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960793-5

7 January 2021

based on heuristic

inferred from DOI database lookup

VTE, thrombophilia, antithrombotic therapy, and pregnancy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960793-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Low-molecular-weight heparins for thromboprophylaxis and treatment of venous thromboembolism in pregnancy: a systematic review of safety and efficacy.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960793-5

7 January 2021

based on heuristic

inferred from DOI database lookup

A new and improved population-based Canadian reference for birth weight for gestational age.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960793-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960793-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Frequency of pregnancy-related venous thromboembolism in anticoagulant factor-deficient women: implications for prophylaxis.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960793-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Fetal and maternal contributions to risk of pre-eclampsia: population based study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960793-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Risk factors associated with preeclampsia in healthy nulliparous women. The Calcium for Preeclampsia Prevention (CPEP) Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960793-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Participation of pregnant women in clinical trials: will they participate and why?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960793-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Antithrombotic prophylaxis for women with thrombophilia and pregnancy complications – Yes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960793-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Antithrombotic therapy and pregnancy: consensus report and recommendations for prevention and treatment of venous thromboembolism and adverse pregnancy outcomes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960793-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Screening for thrombophilia and antithrombotic prophylaxis in pregnancy: Guidelines of the Italian Society for Haemostasis and Thrombosis (SISET).

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960793-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy and safety of two doses of enoxaparin in women with thrombophilia and recurrent pregnancy loss: the LIVE-ENOX study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960793-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Preventing adverse obstetric outcomes in women with genetic thrombophilia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960793-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Low-molecular-weight heparin for the prevention of obstetric complications in women with thrombophilias

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960793-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Management of heparin-associated thrombocytopenia in pregnancy with subcutaneous r-hirudin

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960793-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Thromboprophylaxis for recurrent miscarriage in women with or without thrombophilia. HABENOX: a randomised multicentre trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960793-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Aspirin plus heparin or aspirin alone in women with recurrent miscarriage

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960793-5

7 January 2021

based on heuristic

inferred from DOI database lookup

SPIN (Scottish Pregnancy Intervention) study: a multicenter, randomized controlled trial of low-molecular-weight heparin and low-dose aspirin in women with recurrent miscarriage.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960793-5

7 January 2021

based on heuristic

inferred from DOI database lookup

A randomized study of thromboprophylaxis in women with unexplained consecutive recurrent miscarriages

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960793-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Low molecular weight heparin and aspirin for recurrent pregnancy loss: results from the randomized, controlled HepASA Trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960793-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Low-molecular-weight heparin versus low-dose aspirin in women with one fetal loss and a constitutional thrombophilic disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960793-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment options and pregnancy outcome in women with idiopathic recurrent miscarriage: a randomized placebo-controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960793-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Low-molecular weight heparin in patients with recurrent early miscarriages of unknown aetiology

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960793-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Meta-analysis of low-molecular-weight heparin to prevent recurrent placenta-mediated pregnancy complications

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960793-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Low-molecular-weight heparin added to aspirin in the prevention of recurrent early-onset pre-eclampsia in women with inheritable thrombophilia: the FRUIT-RCT.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960793-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Dalteparin for the prevention of recurrence of placental-mediated complications of pregnancy in women without thrombophilia: a pilot randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960793-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Heparin in pregnant women with previous placenta-mediated pregnancy complications: a prospective, randomized, multicenter, controlled clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960793-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Low-molecular-weight heparin lowers the recurrence rate of preeclampsia and restores the physiological vascular changes in angiotensin-converting enzyme DD women

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960793-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Addition of enoxaparin to aspirin for the secondary prevention of placental vascular complications in women with severe pre-eclampsia. The pilot randomised controlled NOH-PE trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960793-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Enoxaparin for the secondary prevention of placental vascular complications in women with abruptio placentae. The pilot randomised controlled NOH-AP trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960793-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0140-6736(14)60793-5

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/25066248

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/25066248

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53086376&oldid=1398229440"